Geneva
Switzerland
59
2022-10-06
56
2025-10-21
These are the the leading inventors for applications assigned to NovImmune S.A.:
NovImmune S.A. based in Geneva, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
BISPECIFIC ANTIBODIES TARGETING CD47 AND PD-L1 AND METHODS OF USE THEREOF
#2 | 2022-10-06 ✅ Patent 12,583,922 granted on 2026-03-24BISPECIFIC ANTIBODIES TARGETING CD47 AND PD-L1 AND METHODS OF USE THEREOF
#3 | 2020-11-12 ✅ Patent 11,613,582 granted on 2023-03-28Anti-IL-6/IL-6R antibodies and methods of use thereof
#4 | 2020-07-23READILY ISOLATED BISPECIFIC ANTIBODIES WITH NATIVE IMMUNOGLOBULIN FORMAT
#5 | 2020-07-02 ✅ Patent 10,982,004 granted on 2021-04-20Anti-TLR4 antibodies and uses thereof
#6 | 2020-03-26 ✅ Patent 11,827,703 granted on 2023-11-28Compositions and methods related to anti-CD19 antibody drug conjugates
#7 | 2019-09-19 ✅ Patent 11,203,646 granted on 2021-12-21Anti-CD3 epsilon antibodies and methods of use thereof
#8 | 2019-01-31 ✅ Patent 11,401,299 granted on 2022-08-02Generating multispecific antibody mixtures and methods of uses thereof
#9 | 2018-12-13ANTI-CD47 ANTIBODIES AND METHODS OF USE THEREOF
#10 | 2018-11-29 ✅ Patent 11,260,117 granted on 2022-03-01Anti-CD47 x anti-mesothelin antibodies and methods of use thereof
#11 | 2018-10-11 ✅ Patent 11,840,553 granted on 2023-12-12Anti-CD47 antibodies and methods of use thereof
#12 | 2018-10-04 ✅ Patent 10,844,132 granted on 2020-11-24Neutralizing antibodies and methods of use thereof
#13 | 2018-07-12 ✅ Patent 10,759,858 granted on 2020-09-01Anti-CD3 antibodies and methods of use thereof
#14 | 2018-05-17 ✅ Patent 10,689,461 granted on 2020-06-23Antibody dual display dual compositions and methods of use thereof
#15 | 2018-05-10 ✅ Patent 10,597,465 granted on 2020-03-24Methods for the generation of multispecific and multivalent antibodies
#16 | 2018-03-29 ✅ Patent 10,759,862 granted on 2020-09-01Anti-IL-6/IL-6R antibodies and methods of use thereof
#17 | 2018-03-01 ✅ Patent 10,494,446 granted on 2019-12-03Readily isolated bispecific antibodies with native immunoglobulin format
#18 | 2017-10-19 ✅ Patent 10,556,960 granted on 2020-02-11Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of TLR4 ligands and other biomarkers
#19 | 2017-09-21 ✅ Patent 10,421,809 granted on 2019-09-24Anti-TLR4 antibodies and uses thereof
#20 | 2017-01-12 ✅ Patent 10,400,044 granted on 2019-09-03Anti-TLR4 antibodies and uses thereof
#21 | 2016-10-06 ✅ Patent 10,113,193 granted on 2018-10-30Method for optimizing the assembly and production of hetero-multimeric protein complexes
#22 | 2016-09-15 ✅ Patent 10,457,749 granted on 2019-10-29Methods of purifying bispecific antibodies
#23 | 2015-06-11 ✅ Patent 10,689,441 granted on 2020-06-23Anti—TLR4 antibodies and methods of use thereof
#24 | 2015-05-14 ✅ Patent 9,475,873 granted on 2016-10-25Nucleic acids encoding anti-IL-17F antibodies and methods of use thereof
#25 | 2015-04-23 ✅ Patent 9,688,769 granted on 2017-06-27Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of TLR4 ligands and other biomarkers
#26 | 2015-04-02 ✅ Patent 11,261,262 granted on 2022-03-01Readily isolated bispecific binding molecules with native format having mutated constant regions
#27 | 2015-01-08 ✅ Patent 9,512,221 granted on 2016-12-06Anti-TLR4 antibodies and methods of use thereof
#28 | 2014-12-04 ✅ Patent 9,540,444 granted on 2017-01-10Neutralizing antibodies and methods of use thereof
#29 | 2014-10-23 ✅ Patent 9,534,049 granted on 2017-01-03Neutralizing antibodies and methods of use thereof
#30 | 2014-10-09 ✅ Patent 11,059,910 granted on 2021-07-13Anti-CD47 antibodies and methods of use thereof
#31 | 2014-07-03 ✅ Patent 9,682,142 granted on 2017-06-20Anti-interferon gamma antibodies and methods of use thereof
#32 | 2014-06-26 ✅ Patent 9,926,382 granted on 2018-03-27Methods for the generation of multispecific and multivalent antibodies
#33 | 2014-04-10ANTI-IL-17F ANTIBODIES AND METHODS OF USE THEREOF
#34 | 2014-02-06 ✅ Patent 9,688,755 granted on 2017-06-27Fc receptor-binding polypeptides with modified effector functions
#35 | 2013-11-28 ✅ Patent 10,047,144 granted on 2018-08-14Methods of purifying antibodies
#36 | 2013-11-28 ✅ Patent 9,453,076 granted on 2016-09-27Anti-TLR4 antibodies and uses thereof
#37 | 2013-08-01 ✅ Patent 9,650,437 granted on 2017-05-16Nucleic acid encoding and method of producing anti-IL-17A/IL-17F cross-reactive antibodies
#38 | 2013-05-16 ✅ Patent 9,234,034 granted on 2016-01-12Methods of treating autoimmune diseases using anti-IL6/IL-6R complex antibodies
#39 | 2012-10-25 ✅ Patent 8,771,697 granted on 2014-07-08Methods of treatment using anti-IL-17A/IL-17F cross-reactive antibodies
#40 | 2012-08-09 ✅ Patent 8,673,299 granted on 2014-03-18Anti-RANTES antibodies
#41 | 2012-07-12 ✅ Patent 8,734,790 granted on 2014-05-27Anti-TLR4 antibodies and methods of use thereof
#42 | 2012-06-14 ✅ Patent 8,617,880 granted on 2013-12-31Chimeric toll-like receptor/MD-2 polypeptides and methods of use thereof
#43 | 2012-06-14 ✅ Patent 8,609,822 granted on 2013-12-17Neutralizing antibodies and methods of use thereof
#44 | 2012-06-07 ✅ Patent 8,546,539 granted on 2013-10-01Fc receptor-binding polypeptides with modified effector functions
#45 | 2012-06-07 ✅ Patent 8,715,669 granted on 2014-05-06Anti-IL-17A/IL-17F cross-reactive antibodies
#46 | 2012-01-26 ✅ Patent 8,337,849 granted on 2012-12-25Anti-IL6/IL-6R antibodies
#47 | 2011-05-19 ✅ Patent 8,716,196 granted on 2014-05-06Synthetic polypeptide libraries and methods for generating naturally diversified polypeptide variants
#48 | 2011-03-17 ✅ Patent 8,921,281 granted on 2014-12-30Synthetic polypeptide libraries and methods for generating naturally diversified polypeptide variants
#49 | 2011-01-06 ✅ Patent 8,034,344 granted on 2011-10-11Anti-IL-6/IL-6R antibodies and methods of use thereof
#50 | 2010-12-23 ✅ Patent 8,258,267 granted on 2012-09-04Human anti-IP-10 antibodies uses thereof
#51 | 2010-10-21 ✅ Patent 8,106,018 granted on 2012-01-31Chimeric toll-like receptor/MD-2 polypeptides and methods of use thereof
#52 | 2010-07-22 ✅ Patent 8,105,595 granted on 2012-01-31Methods of using neutralizing anti-TLR4/MD2 antibodies
#53 | 2010-07-22 ✅ Patent 8,551,478 granted on 2013-10-08Anti-CD3 antibodies and methods of use thereof
#54 | 2009-07-02 ✅ Patent 7,786,268 granted on 2010-08-31Anti-IP-10 antibodies and methods of use thereof
#55 | 2008-05-22 ✅ Patent 7,744,884 granted on 2010-06-29Neutralizing antibodies and methods of use thereof
#56 | 2008-02-28 ✅ Patent 7,674,884 granted on 2010-03-09Neutralizing antibodies and methods of use thereof
#57 | 2006-11-23 ✅ Patent 7,700,098 granted on 2010-04-20Anti-interferon gamma antibodies and methods of use thereof
#58 | 2006-08-10 ✅ Patent 7,728,114 granted on 2010-06-01Anti-CD3 antibodies and methods of use thereof
#59 | 2006-07-27 ✅ Patent 8,029,794 granted on 2011-10-04Combining therapies targeting multiple toll-like receptors
Also check out NovImmune SA's (Geneva, Switzerland) applicant profile with 44 patent applications submitted.
22785 ⎘